| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Pyxis Oncology, Inc. | Director | Stock Option (Right to Buy) | 36,979 | $36,239 | $0.9800 | 31 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | 31 Mar 2025 | 1 | +$36,239 | 4 | Director | 02 Apr 2025, 08:55 |
| PYXS | Pyxis Oncology, Inc. | 26 Mar 2024 | 1 | $0 | 4 | Director | 28 Mar 2024, 16:33 |
| PYXS | Pyxis Oncology, Inc. | 24 Mar 2023 | 1 | $0 | 4 | Director | 28 Mar 2023, 16:43 |
| PYXS | Pyxis Oncology, Inc. | 31 Mar 2022 | 1 | $0 | 4 | Director | 04 Apr 2022, 16:16 |
| PYXS | Pyxis Oncology, Inc. | 13 Oct 2021 | 2 | $0 | 4 | Director | 15 Oct 2021, 17:35 |
| PYXS | Pyxis Oncology, Inc. | 07 Oct 2021 | 1 | $0 | 4 | Director | 12 Oct 2021, 19:47 |
| PYXS | Pyxis Oncology, Inc. | 07 Oct 2021 | 0 | $0 | 3 | Director | 07 Oct 2021, 21:21 |